as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus. HealthDay News — The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) ...

Sign up for our newsletter to get updates to your inbox, and also receive offers from us, our affiliates and partners. By signing up you agree to our Privacy Policy ...

Lomar Seecharran scored 90 and Munish Outar grabbed 5-25 to highlight the third round of the GCA Mayor’s Cup 100 Overs U-17 tournament yesterday. At the Transport Sport Club (TSC) Apple followed up ...

On this episode of Not So Different, we explore the Federal Trade Commission’s (FTC) second interim report on pharmacy benefit managers (PBMs) with Joe Wisniewski from Turquoise Health, discussing key ...

Merilog administered subcutaneously 5 to 10 minutes before mealtime helps improve glycemic control. (HealthDay News) — The US Food and Drug Administration has approved Merilog (insulin-aspart ...

Hyperinsulinemia occurs when the body has higher insulin levels than usual. It is linked to insulin resistance and diabetes. Hyperinsulinemia can affect blood sugar levels and how effectively the ...

Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to Novo Nordisk’s Novolog) that helps control blood sugar spikes when taken five to 10 minutes before a meal.

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...

The rollout of California’s program to develop low-cost copycat versions of insulin, known as biosimilars, remains more than a year away from distribution, a top official told state lawmakers ...